What's in Laboratories Leon Farma, S.A.'s pipeline?

Laboratories Leon Farma, S.A. has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Laboratories Leon Farma, S.A.'s portfolio?

Top competitors by shared drug class: Bayer, Baylor Research Institute, Bio Meds Pharmaceutica Ltda, Bristol-Myers Squibb, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/laboratories-leon-farma-s-a.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Laboratories Leon Farma, S.A. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Laboratories Leon Farma, S.A. pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
LF111 (drospirenone)	LF111 (drospirenone)	phase 3	Progestin	Progesterone receptor; mineralocorticoid receptor antagonist	Contraception / Gynecology

Therapeutic area mix

Contraception / Gynecology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bayer · 1 shared drug class
Baylor Research Institute · 1 shared drug class
Bio Meds Pharmaceutica Ltda · 1 shared drug class
Bristol-Myers Squibb · 1 shared drug class
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · 1 shared drug class
Exeltis Usa Inc · 1 shared drug class
Fdn Consumer · 1 shared drug class
· 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Laboratories Leon Farma, S.A.:

Cite this brief

Drug Landscape (2026). Laboratories Leon Farma, S.A. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/laboratories-leon-farma-s-a. Accessed 2026-05-17.